Merola, Joseph F. http://orcid.org/0000-0001-6514-4353
Patil, Dhaval
Egana, Antton
Steffens, Andrea
Webb, Noah S.
Gottlieb, Alice B.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 6 July 2023
Accepted: 30 August 2023
First Online: 19 September 2023
Declarations
:
: Joseph F. Merola is a consultant and/or investigator for Amgen, Arcutis, Bristol Myers Squibb, AbbVie, Dermavant, Eli Lilly, Novartis, Janssen, UCB, Sanofi, Regeneron, Sun Pharma, Biogen, Pfizer, and LEO Pharma. Dhaval Patil and Antton Egana are employees of Novartis Pharmaceuticals Corporation. Andrea Steffens and Noah S. Webb are employees of Optum. Alice B. Gottlieb has received honoraria as an advisory board member and consultant for Amgen, AnaptysBio, Avotres Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Dice Therapeutics, Eli Lilly, Janssen, Novartis, Sanofi, UCB, and Xbiotech, and has received research/educational grants from AnaptysBio, MoonLake Immunotherapeutics AG, Novartis, Bristol Myers Squibb, and UCB Pharma (all paid to Mount Sinai School of Medicine).
: Because the current study used only deidentified patient records and did not involve the collection, use, or transmittal of individually identifiable data, institutional review board approval was not required to conduct this study. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.